Its ability to restore Claudin-1-mediated TJ and BBB function through the activation of C/EBP- signaling offers a potential approach to protect against stroke-induced neuronal damage
More serious concerns include: Acute pancreatitis : If severe, persistent abdominal pain occurs, possibly radiating to the back, with or without vomiting, treatment should be discontinued immediately and urgent medical attention sought Gallbladder disease : GLP-1 medications and weight loss can increase the risk of gallstones and cholecystitis
Understanding how tirzepatide works is key to seeing its benefits
Nature 485 , 459464 (2012)
Saxenda Lawsuit Update 2025 With more research and more severe cases coming forward, many patients are realizing their severe reactions were actually common side effects, and have started filing Saxenda lawsuits
Saxenda (liraglutide) Saxenda is a GLP-1 medication appropriate for adults who: Have obesity (BMI of 30 or above) Have overweight (BMI of 27 or above) along with a weight-related comorbid condition like high blood pressure, type 2 diabetes, or high cholesterol or triglycerides It is also approved for children ages 12 and above who weigh more than 132 pounds and are considered obese